177Lu-DOTATATE Shows Promising Efficacy in the Treatment of Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas By Ogkologos - September 2, 2025 125 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the Phase II study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR Study Details Long-Term Side Effects of Immune Checkpoint Inhibitors April 30, 2021 Adding Pembrolizumab to Chemotherapy with or without Bevacizumab Improves Overall Survival... January 9, 2024 New Super-Microsurgical Procedure May Prevent Lymphedema in Breast Cancer Patients March 2, 2020 ESMO 2024 Press Conference September 13, 2024 Load more HOT NEWS Managing Cancer Pain: Are Better Approaches on the Horizon? Simple Hysterectomy Noninferior to Radical Hysterectomy with Respect to Pelvic Recurrence... Study Finds Accelerated Partial-Breast Radiation Just as Effective as Whole Breast... Dogs Can Sniff Out COVID-19 After Just One Week Of Training,...
